Director, Assistant Controller

Aktis Oncology, Inc.; Boston (MA); Hybrid; USD 196,000 - 240,000; Full time

Job summary

Aktis Oncology, Inc. is a clinical-stage oncology company seeking an Assistant Controller. You will manage accounting operations, financial close, and internal controls, serving as the primary accounting partner for R&D teams.

This Boston-based, on-site/hybrid role reports to the Senior Director, Controller. The position demands a CPA and 7–10 years of relevant experience, with a strong emphasis on GAAP, SOX controls, and cross-functional collaboration across R&D, CMC and Clinical teams.

Qualifications

• Bachelor’s degree with CPA license and 7-10 years related experience required.
• 3-5 years with life science companies preferred.
• Demonstrated knowledge of GAAP and SOX controls.

Responsibilities

• Oversee and maintain the general ledger with accurate classifications.
• Lead monthly close process with journal entries, reconciliations, and reports.
• Support development and implementation of internal controls and audit readiness.
• Develop scalable accounting policies, processes and systems including SOX preparedness.

Skills

GAAP knowledge

SOX controls

Financial reporting

Process improvement

Cross-functional collaboration

Education

Bachelor’s degree with CPA license

Tools

NetSuite

Prendio

Job description

If you are unable to complete this application due to a disability, contact this employer to ask for an accommodation or an alternative application process.

G&A: Finance Boston, MA, US

6 days ago Requisition ID: 1058

Salary Range: $196,200.00 To $239,800.00 Annually

Aktis Oncology, Inc. is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. Aktis' most advanced program, AKY-1189, is a miniprotein radioconjugate targeting Nectin-4, with multi-indication potential across multiple tumor types, including locally advanced or metastatic urothelial cancer, breast cancer, non-small cell lung cancer, colorectal cancer, cervical cancer, and head and neck cancer. Aktis' second pipeline program, AKY-2519, is a miniprotein radioconjugate targeting B7-H3 expressing tumors, including prostate, lung and other solid tumors. Aktis has a strategic collaboration with Eli Lilly and Company to leverage its miniprotein platform to develop novel radioconjugates outside of Aktis' proprietary pipeline.

Aktis Oncology is seeking a highly motivated Assistant Controller with a strong background in accounting operations, financial reporting, and internal controls. In this high-impact role, you will report to and be the trusted right hand to the Senior Director, Controller. You will be responsible for managing key accounting activities and the financial close process, leading process improvement initiatives and building strong, collaborative relationships across the organization. Importantly, you will act as the primary accounting partner for R&D teams, establishing an in-depth knowledge of activities to ensure proper controls, accounting and financial disclosure.

This position is a Boston-based on-site/hybrid role with one day a week in our corporate headquarters.

Responsibilities

• Oversee and maintain the general ledger, ensuring all financial transactions are accurately recorded and properly classified.
• Lead the monthly close process, including preparing and reviewing journal entries, reconciliations, fluctuation analysis, and financial reports.
• Support the development and implementation of internal controls and maintain evidence of the performance of internal controls to ensure compliance and audit readiness.
• Assist with the development of scalable accounting policies, processes and systems to support potential future public company reporting, including SOX preparedness.
• Identify and implement technology-driven improvements in financial processes to enhance efficiency, accuracy, and scalability.
• Collaborate closely with R&D leaders to establish an in-depth knowledge of functional priorities, workstreams, contracts and external relationships.
• Oversee process development and quarterly execution of critical R&D expense accrual and revenue recognition assessments.
• Together with FP&A, act as a business partner to R&D teams, providing support and guidance as needed to ensure accurate and effective flow of financial information.

Qualifications

• Minimum of a Bachelor’s degree with CPA license and 7-10 years related experience required.
• At least 3-5 years with life science companies.
• Hands-on experience working in both private and public company settings.
• Demonstrated knowledge of GAAP and SOX controls.
• Demonstrated managerial capability in a growing and changing company:
  • ability to initiate and make improvements to processes and procedures;
  • ability to adapt to changing priorities;
  • ability and desire to supervise, as well as perform the detailed work;
  • ability to focus on detail while understanding the relevance and application of that detail to the larger business at hand.
• Demonstrated success collaborating within finance and cross-functionally (with particular emphasis on Research, CMC and Clinical teams).
• Working knowledge and experience with financial systems - NetSuite, Prendio - strongly preferred.
• Strong, demonstrated workplace skills, including but not limited to:
  • time management - schedules, timelines, task prioritization;
  • communication - written and verbal; ability to coordinate and interact with all levels and functions;
  • analytical and organizational.

Aktis Oncology is an Equal Opportunity Employer and does not discriminate on the basis of race, religion, color, sex, gender identity or expression, sexual orientation, age, disability, national origin, veteran status, or any other basis covered by appropriate law. Aktis Oncology is committed to promoting and maintaining a work environment in which all applicants, employees, and other individuals are treated with dignity and respect free from unlawful harassment, discrimination, or retaliation.